Nestle Expands Health Science Business With US Acquisition

 Breaking News
  • Guinness Remains Ireland’s Most Valuable Brand at €2.1 Billion Guinness remains Ireland’s most valuable brand after growing by 5% over the last year to a brand value of €2.1 billion on the back of new product innovations and steady sales of the world-famous draught, according to the latest report by Brand Finance, the world’s leading independent brand valuation and strategy consultancy. Guinness’s brand value has [...]...
  • New Décor Salt Convinces With a Crunchy Bite and High Stability When it comes to pretzels or salt sticks, the visual contrast between a dark crust and a rich salt décor is a mark of quality for most consumers. New Slow Milling® Pretzel Salt Light SG from GoodMills Innovation enables salt reduction in pretzel décor without the consumer noticing any visible difference. At the same time, [...]...
  • DuPont’s Microbiome Venture Announces Second Strategic Partnership Three months after its formation, the DuPont Nutrition & Health Microbiome Venture has announced its second strategic research and development partnership. The newly forged relationship with the Center of Food and Fermentation Technologies (TFTAK) in Tallinn, Estonia, will focus on developing cultivation and bioprocess capabilities for ‘next-generation’ probiotics. Last November, DuPont Nutrition & Health (DuPont) announced [...]...
  • JBT Announces Comprehensive Relaunch of Online Presence JBT Corporation, one of the world’s leading solutions providers for the food and beverage processing industries, has announced the comprehensive relaunch of its online presence, with the introduction of a redesigned flagship website. To better accommodate a range of solutions that includes not just core JBT products, but also innovations from its global businesses and [...]...
  • Building the Unilever of the Future Unilever has announced the next steps in its transformation into a simpler, more agile and more focused business. The changes are designed to further drive long-term performance and shareholder value, and build upon the company’s Connected 4 Growth programme. Unilever will simplify its corporate structure. This entails moving from two legal entities – Unilever NV and [...]...

Nestle Expands Health Science Business With US Acquisition

Nestle Expands Health Science Business With US Acquisition
May 27
10:38 2011

Nestle Health Science has agreed to acquire Prometheus Laboratories, a San Diego-based company. Prometheus specialises in diagnostics and in-licensed specialty pharmaceuticals in gastroenterology and oncology, and has a dedicated team of highly qualified medical sales representatives. The company focuses on conditions such as inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis. The terms of the transaction, which is subject to regulatory approval, are not being disclosed.

The deal is in line with Nestle Health Science’s ambition of pioneering science-based nutritional solutions to deliver improved personalised health care for medical conditions.

“This acquisition is a strategic move into gastrointestinal diagnostics,” points out Luis Cantarell, president and chief executive of Nestle Health Science. “Prometheus’s leading edge diagnostics and highly experienced medical sales representatives together constitute a robust platform for Nestle Health Science to accelerate its current and future healthcare business. It will enable new personalised healthcare solutions based on diagnostics, pharma and nutrition.”

Prometheus’s strong expertise and R&D in gastrointestinal diagnostics will accelerate the research program that is being established in the newly-created Nestlé Institute of Health Sciences. It will create new opportunities for developing personalised nutrition strategies that will help in the management and prevention of chronic health conditions. The R&D pipeline will encompass other areas of strategic interest for Nestle Health Science, such as metabolic conditions and brain health.

About 500 employees of Prometheus will join Nestle Health Science as a result of the acquisition. In 2012 Prometheus’s annualised sales are expected to be around $250 million.

About Author



Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • March 18, 2018ProWein
  • March 21, 2018World Olive Oil Exhibition
  • March 28, 2018FOOD INDUSTRY
  • April 4, 2018The leading event for the snack and food-on-the-go market
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here